Circuit lifespan during continuous renal replacement therapy for combined liver and kidney failure
Authors:
- Ian BaldwinIBIan Baldwin
- Michael BaileyMBMichael Bailey
- Ashwin SubramaniamASAshwin Subramaniam
- Rinaldo BellomoRBRinaldo Bellomo
- 1 December 2012
- journal article
- Published by Elsevier in Journal of Critical Care
- Vol. 27 (6) , 744.e7-744.e15
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- The Coagulopathy of Chronic Liver DiseaseNew England Journal of Medicine, 2011
- Heparin-induced thrombocytopenia in the ICU: an overviewCritical Care, 2011
- Hemostasis and thrombosis in patients with liver disease: The ups and downsJournal of Hepatology, 2010
- Detection of the Imbalance of Procoagulant Versus Anticoagulant Factors in Cirrhosis by a Simple Laboratory MethodHepatology, 2010
- Bacteremia, Acute Physiology and Chronic Health Evaluation II and Modified End Stage Liver Disease are independent predictors of mortality in critically ill nontransplanted patients with acute on chronic liver failureCritical Care Medicine, 2010
- Management of adult patients with ascites due to cirrhosisHepatology, 2009
- Relevance of clotting tests in liver diseasePostgraduate Medical Journal, 2008
- Comprehensive analysis of ADAMTS13 in patients with liver cirrhosisThrombosis and Haemostasis, 2008
- AASLD position paperHepatology, 2005
- Adverse Effects on Cerebral Perfusion of Prostacyclin Administered Directly into Patients with Fulminant Hepatic Failure and Acute Renal FailureNephron, 1991